Tadd S. Wessel, founder and Managing Partner of Petrichor Healthcare Capital Management, invests primarily in structured credit, royalty. See contact routes.
Tadd S. Wessel, founder and Managing Partner of Petrichor Healthcare Capital Management, invests primarily in structured credit, royalty, and equity deals across therapeutics, diagnostics, and medical technologies, with a current focus on the rare disease market. The firm targets Pharmaceuticals & Biopharmaceuticals, Medical Technology, and Diagnostics, aiming to generate cash yield with downside credit protection and equity-like upside. A notable portfolio investment includes a $2.5 million equity stake in Leukocare in 2021, after which Wessel joined its Supervisory Board. His distinctive thesis centers on supporting healthcare managers and businesses to drive scientific and medical innovation, particularly in life sciences.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Tadd S. Wessel · Full investor directory · Investor access · Company funding database